Skip to main content
. 2020 Jan 31;26(2):216–227. doi: 10.1111/hae.13927

Figure 3.

Figure 3

Prophylaxis administration according to the subtype of inherited platelet receptor defect. GT, Glanzmann thrombasthenia; BSS, Bernard‐Soulier syndrome; PT‐VWD, platelet‐type von Willebrand disease; TxA2, thromboxane A2 receptor defects; P2Y12, ADP receptor defects. Prophylactic treatment for delivery is defined as measures taken to prevent PPH and could consist of blood products (erythrocytes, platelets, plasma, coagulation factors, plasmapheresis), recombinant Factor VIIa (rFVIIa), desmopressin (DDAVP), or other measures. Other = preventive hysterectomy, antifibrinolytics, uterotonic agents, fibrinogen concentrate and steroids